Stock Research for MON

Featured Broker: Ally Invest

Get the due diligence for another stock.


MON Stock Chart & Research Data

The MON chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MON chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MON Due diligence Resources & Stock Charts

The MON stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MON Detailed Price Forecast - CNN Money CNN View MON Detailed Summary - Google Finance
Yahoo View MON Detailed Summary - Yahoo! Finance Zacks View MON Stock Research & Analysis -

Stock Analysis

TradeIdeas View MON Trends & Analysis - Trade-Ideas Barrons View MON Major Holders - Barrons
NASDAQ View MON Call Transcripts - NASDAQ Seeking View MON Breaking News & Analysis - Seeking Alpha
Spotlight View MON Annual Report - OTC Report View MON OTC Short Report -
TradeKing View MON Fundamentals - TradeKing Charts View MON SEC Filings - Bar Chart
WSJ View Historical Prices for MON - The WSJ Morningstar View Performance/Total Return for MON - Morningstar
MarketWatch View the Analyst Estimates for MON - MarketWatch CNBC View the Earnings History for MON - CNBC
StockMarketWatch View the MON Earnings - StockMarketWatch MacroAxis View MON Buy or Sell Recommendations - MacroAxis
Bullish View the MON Bullish Patterns - American Bulls Short Pains View MON Short Pain Metrics -

Social Media Mentions

StockTwits View MON Stock Mentions - StockTwits PennyStocks View MON Stock Mentions - PennyStockTweets
Twitter View MON Stock Mentions - Twitter Invest Hub View MON Investment Forum News - Investor Hub
Yahoo View MON Stock Mentions - Yahoo! Message Board Seeking Alpha View MON Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MON - Insider Cow View Insider Transactions for MON - Insider Cow
CNBC View MON Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MON - OTC Markets
Yahoo View Insider Transactions for MON - Yahoo! Finance NASDAQ View Institutional Holdings for MON - NASDAQ

Stock Charts

FinViz View MON Stock Insight & Charts - StockCharts View MON Investment Charts -
BarChart View MON Stock Overview & Charts - BarChart Trading View View MON User Generated Charts - Trading View

Latest Financial News for MON

Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict
Posted on Tuesday September 18, 2018

The company said in motions filed in San Francisco's Superior Court of California that the jury's decision was insufficiently supported by the evidence presented at trial by school groundskeeper Dewayne Johnson. Johnson's case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin's lymphoma, a cancer of the lymph system, that he alleged was caused by years of exposure to Roundup and Ranger Pro, another Monsanto herbicide that contains glyphosate. Monsanto asked Superior Court Judge Suzanne Bolanos, who oversaw the trial, to set aside the verdict or, in the alternative, reduce the award or grant a new trial.

Bayer cuts forecasts on Monsanto delay as lawsuits pile up
Posted on Wednesday September 05, 2018

Bayer cut its earnings forecast on Wednesday due to delays to its $63 billion takeover of Monsanto, and said sales of its consumer care products fell, hitting its shares, already reeling from a legal battle over the weed killer Roundup. The weaker earnings forecast adds to a number of challenges facing the German drugmaker as it braces for years of legal wrangling over the alleged cancer risks of glyphosate-based weedkillers. Bayer said the number of plaintiffs seeking damages over Monsanto's Roundup and Ranger Pro herbicides had risen to 8,700 from 8,000 from last month, and said that it expected more to sue.

Bayer CEO on Lower Earnings, Monsanto Purchase, Roundup
Posted on Wednesday September 05, 2018

Sep.05 -- Werner Baumann, chief executive officer at Bayer, discusses the company's lower earnings forecast, the Monsanto purchase and the company's Roundup lawsuit. He speaks on "Bloomberg Markets: European Open."

EPA should revoke Monsanto weed killer approval, groups tell U.S. court
Posted on Wednesday August 29, 2018

The groups, which filed a lawsuit in February, want the court to force the EPA to vacate its approval of XtendiMax, arguing it not only harms nearby crops and plants but wildlife as well. It is not clear whether the court has the authority to revoke an EPA approval. The United States has faced a weed-killer crisis caused by the new formulations of dicamba-based herbicides, which farmers and weed experts say have harmed crops because they evaporate and drift away from where they are applied.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.